The Peter Attia Drive

Snapshot · The Peter Attia Drive

#399 ‒ The evolution of Alzheimer's disease and dementia care: how early detection, personalized treatment, new therapies, and a multimodal approach are changing the landscape | Gayatri Devi, M.D.

Explore episode Jul 13, 2026

Where this was said

Case study: early prevention in APOE4 homozygote

At 48:28 · chapter starts 47:15

This case study is the episode's most concrete illustration of early intervention. The patient: a highly functional physician in her 50s who carries two copies of the APOE4 allele — roughly equivalent in risk terms to carrying the BRCA gene for breast cancer — with both parents having confirmed Alzheimer's disease. Asymptomatic but at extreme risk, she underwent a spinal tap that revealed low CSF amyloid (indicating brain deposition) and borderline tau. Despite scoring well overall on cognitive testing, her language fluency and a few memory domains gave Gayatri Devi pause. The treatment decision: start a GLP-1 agonist for metabolic optimization and a monoclonal antibody to clear the early amyloid buildup. The framing is explicitly about changing destiny before symptoms emerge — a fundamentally different posture than the standard clinical wait-for-decline approach.

Similar snapshots